CYCLIC POLYPEPTIDES FOR PCSK9 INHIBITION
Provided herein are cyclic polypeptide compounds that can, e.g., bind specifically to human proprotein convertase subtilisin/kexin type 9 (PCSK9) and optionally also inhibit interaction between human PCSK9 and human low density lipoprotein receptor (LDLR), and pharmaceutical compositions comprising...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KEREKES, Angela, Dawn BRANCA, Danila RICARDO, Alonso INGENITO, Raffaele GILBERT, Eric, J HA, Sookhee, Nicole YOUM, Hyewon STRINGER, Joseph, R CONTE, Immacolata SANTOPRETE, Alessia BIANCHI, Elisabetta COSTANTINI, Willy COLARUSSO, Stefania BOYER, Nicolas, Cedric XIONG, Yusheng TUCKER, Thomas, Joseph LAPLACA, Derek, M WU, Chengwei COSTANTE, Roberto EMBREY, Mark, W SHAHRIPOUR, Aurash |
| description | Provided herein are cyclic polypeptide compounds that can, e.g., bind specifically to human proprotein convertase subtilisin/kexin type 9 (PCSK9) and optionally also inhibit interaction between human PCSK9 and human low density lipoprotein receptor (LDLR), and pharmaceutical compositions comprising one or more of these compounds. Also provided are methods of reducing LDL cholesterol level in a subject in need thereof that include administering to the subject one or more of the cyclic polypeptide compounds or a pharmaceutical composition provided herein. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3810196A4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3810196A4</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3810196A43</originalsourceid><addsrcrecordid>eNrjZNBwjnT28XRWCPD3iQxwDQjxdHENVnDzD1IIcA72tlTw9PPwdPIM8fT342FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxhaGBoaWZo4mxkQoAQDM0SPM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CYCLIC POLYPEPTIDES FOR PCSK9 INHIBITION</title><source>esp@cenet</source><creator>KEREKES, Angela, Dawn ; BRANCA, Danila ; RICARDO, Alonso ; INGENITO, Raffaele ; GILBERT, Eric, J ; HA, Sookhee, Nicole ; YOUM, Hyewon ; STRINGER, Joseph, R ; CONTE, Immacolata ; SANTOPRETE, Alessia ; BIANCHI, Elisabetta ; COSTANTINI, Willy ; COLARUSSO, Stefania ; BOYER, Nicolas, Cedric ; XIONG, Yusheng ; TUCKER, Thomas, Joseph ; LAPLACA, Derek, M ; WU, Chengwei ; COSTANTE, Roberto ; EMBREY, Mark, W ; SHAHRIPOUR, Aurash</creator><creatorcontrib>KEREKES, Angela, Dawn ; BRANCA, Danila ; RICARDO, Alonso ; INGENITO, Raffaele ; GILBERT, Eric, J ; HA, Sookhee, Nicole ; YOUM, Hyewon ; STRINGER, Joseph, R ; CONTE, Immacolata ; SANTOPRETE, Alessia ; BIANCHI, Elisabetta ; COSTANTINI, Willy ; COLARUSSO, Stefania ; BOYER, Nicolas, Cedric ; XIONG, Yusheng ; TUCKER, Thomas, Joseph ; LAPLACA, Derek, M ; WU, Chengwei ; COSTANTE, Roberto ; EMBREY, Mark, W ; SHAHRIPOUR, Aurash</creatorcontrib><description>Provided herein are cyclic polypeptide compounds that can, e.g., bind specifically to human proprotein convertase subtilisin/kexin type 9 (PCSK9) and optionally also inhibit interaction between human PCSK9 and human low density lipoprotein receptor (LDLR), and pharmaceutical compositions comprising one or more of these compounds. Also provided are methods of reducing LDL cholesterol level in a subject in need thereof that include administering to the subject one or more of the cyclic polypeptide compounds or a pharmaceutical composition provided herein.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220504&DB=EPODOC&CC=EP&NR=3810196A4$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220504&DB=EPODOC&CC=EP&NR=3810196A4$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KEREKES, Angela, Dawn</creatorcontrib><creatorcontrib>BRANCA, Danila</creatorcontrib><creatorcontrib>RICARDO, Alonso</creatorcontrib><creatorcontrib>INGENITO, Raffaele</creatorcontrib><creatorcontrib>GILBERT, Eric, J</creatorcontrib><creatorcontrib>HA, Sookhee, Nicole</creatorcontrib><creatorcontrib>YOUM, Hyewon</creatorcontrib><creatorcontrib>STRINGER, Joseph, R</creatorcontrib><creatorcontrib>CONTE, Immacolata</creatorcontrib><creatorcontrib>SANTOPRETE, Alessia</creatorcontrib><creatorcontrib>BIANCHI, Elisabetta</creatorcontrib><creatorcontrib>COSTANTINI, Willy</creatorcontrib><creatorcontrib>COLARUSSO, Stefania</creatorcontrib><creatorcontrib>BOYER, Nicolas, Cedric</creatorcontrib><creatorcontrib>XIONG, Yusheng</creatorcontrib><creatorcontrib>TUCKER, Thomas, Joseph</creatorcontrib><creatorcontrib>LAPLACA, Derek, M</creatorcontrib><creatorcontrib>WU, Chengwei</creatorcontrib><creatorcontrib>COSTANTE, Roberto</creatorcontrib><creatorcontrib>EMBREY, Mark, W</creatorcontrib><creatorcontrib>SHAHRIPOUR, Aurash</creatorcontrib><title>CYCLIC POLYPEPTIDES FOR PCSK9 INHIBITION</title><description>Provided herein are cyclic polypeptide compounds that can, e.g., bind specifically to human proprotein convertase subtilisin/kexin type 9 (PCSK9) and optionally also inhibit interaction between human PCSK9 and human low density lipoprotein receptor (LDLR), and pharmaceutical compositions comprising one or more of these compounds. Also provided are methods of reducing LDL cholesterol level in a subject in need thereof that include administering to the subject one or more of the cyclic polypeptide compounds or a pharmaceutical composition provided herein.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBwjnT28XRWCPD3iQxwDQjxdHENVnDzD1IIcA72tlTw9PPwdPIM8fT342FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxhaGBoaWZo4mxkQoAQDM0SPM</recordid><startdate>20220504</startdate><enddate>20220504</enddate><creator>KEREKES, Angela, Dawn</creator><creator>BRANCA, Danila</creator><creator>RICARDO, Alonso</creator><creator>INGENITO, Raffaele</creator><creator>GILBERT, Eric, J</creator><creator>HA, Sookhee, Nicole</creator><creator>YOUM, Hyewon</creator><creator>STRINGER, Joseph, R</creator><creator>CONTE, Immacolata</creator><creator>SANTOPRETE, Alessia</creator><creator>BIANCHI, Elisabetta</creator><creator>COSTANTINI, Willy</creator><creator>COLARUSSO, Stefania</creator><creator>BOYER, Nicolas, Cedric</creator><creator>XIONG, Yusheng</creator><creator>TUCKER, Thomas, Joseph</creator><creator>LAPLACA, Derek, M</creator><creator>WU, Chengwei</creator><creator>COSTANTE, Roberto</creator><creator>EMBREY, Mark, W</creator><creator>SHAHRIPOUR, Aurash</creator><scope>EVB</scope></search><sort><creationdate>20220504</creationdate><title>CYCLIC POLYPEPTIDES FOR PCSK9 INHIBITION</title><author>KEREKES, Angela, Dawn ; BRANCA, Danila ; RICARDO, Alonso ; INGENITO, Raffaele ; GILBERT, Eric, J ; HA, Sookhee, Nicole ; YOUM, Hyewon ; STRINGER, Joseph, R ; CONTE, Immacolata ; SANTOPRETE, Alessia ; BIANCHI, Elisabetta ; COSTANTINI, Willy ; COLARUSSO, Stefania ; BOYER, Nicolas, Cedric ; XIONG, Yusheng ; TUCKER, Thomas, Joseph ; LAPLACA, Derek, M ; WU, Chengwei ; COSTANTE, Roberto ; EMBREY, Mark, W ; SHAHRIPOUR, Aurash</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3810196A43</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KEREKES, Angela, Dawn</creatorcontrib><creatorcontrib>BRANCA, Danila</creatorcontrib><creatorcontrib>RICARDO, Alonso</creatorcontrib><creatorcontrib>INGENITO, Raffaele</creatorcontrib><creatorcontrib>GILBERT, Eric, J</creatorcontrib><creatorcontrib>HA, Sookhee, Nicole</creatorcontrib><creatorcontrib>YOUM, Hyewon</creatorcontrib><creatorcontrib>STRINGER, Joseph, R</creatorcontrib><creatorcontrib>CONTE, Immacolata</creatorcontrib><creatorcontrib>SANTOPRETE, Alessia</creatorcontrib><creatorcontrib>BIANCHI, Elisabetta</creatorcontrib><creatorcontrib>COSTANTINI, Willy</creatorcontrib><creatorcontrib>COLARUSSO, Stefania</creatorcontrib><creatorcontrib>BOYER, Nicolas, Cedric</creatorcontrib><creatorcontrib>XIONG, Yusheng</creatorcontrib><creatorcontrib>TUCKER, Thomas, Joseph</creatorcontrib><creatorcontrib>LAPLACA, Derek, M</creatorcontrib><creatorcontrib>WU, Chengwei</creatorcontrib><creatorcontrib>COSTANTE, Roberto</creatorcontrib><creatorcontrib>EMBREY, Mark, W</creatorcontrib><creatorcontrib>SHAHRIPOUR, Aurash</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KEREKES, Angela, Dawn</au><au>BRANCA, Danila</au><au>RICARDO, Alonso</au><au>INGENITO, Raffaele</au><au>GILBERT, Eric, J</au><au>HA, Sookhee, Nicole</au><au>YOUM, Hyewon</au><au>STRINGER, Joseph, R</au><au>CONTE, Immacolata</au><au>SANTOPRETE, Alessia</au><au>BIANCHI, Elisabetta</au><au>COSTANTINI, Willy</au><au>COLARUSSO, Stefania</au><au>BOYER, Nicolas, Cedric</au><au>XIONG, Yusheng</au><au>TUCKER, Thomas, Joseph</au><au>LAPLACA, Derek, M</au><au>WU, Chengwei</au><au>COSTANTE, Roberto</au><au>EMBREY, Mark, W</au><au>SHAHRIPOUR, Aurash</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CYCLIC POLYPEPTIDES FOR PCSK9 INHIBITION</title><date>2022-05-04</date><risdate>2022</risdate><abstract>Provided herein are cyclic polypeptide compounds that can, e.g., bind specifically to human proprotein convertase subtilisin/kexin type 9 (PCSK9) and optionally also inhibit interaction between human PCSK9 and human low density lipoprotein receptor (LDLR), and pharmaceutical compositions comprising one or more of these compounds. Also provided are methods of reducing LDL cholesterol level in a subject in need thereof that include administering to the subject one or more of the cyclic polypeptide compounds or a pharmaceutical composition provided herein.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3810196A4 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | CYCLIC POLYPEPTIDES FOR PCSK9 INHIBITION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T05%3A23%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KEREKES,%20Angela,%20Dawn&rft.date=2022-05-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3810196A4%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |